New treatment approaches for lung cancer and impact on survival . Seminars in oncology . 2002; 29 ( 3 Suppl 8):26–9. PubMed PMID: .Cortes-Funes H. New treatment approaches for lung cancer and impact on survival. Semin Oncol. 2002; 29 :26–29....
Chicago—With lung cancer claiming the lives of more men and women than colon, breast, and prostate cancers combined, the need for agents to prevent this malignancy has never been more urgent. Although efforts have been unsuccessful to date, preliminary research reported here at the recent Annual...
53 CTffr Versus Stress Imaging for Acute Chest Pain Patients 54:41 Genitourinary and Gynecological Causes of Acute Abdominal Pain 59:59 Lung Cancer Screening 1:09:37 Lymphoma Case-based Multidisciplinary Review 1:04:21 Neonatal Imaging 1:00:13 Pancreatic Tumor Imaging 1:10:00 Post-treatment ...
Oncologists are encouraged by the number of immunotherapies to treat non-small cell lung cancer, but they still want more options, especially for advanced cases, according … Sign up to read this article for ...
The identification of such mechanisms may open new avenues for the prevention and treatment of HCC through the development of targeted therapies. In this review we will describe the new potential therapeutic targets and clinical developments that have emerged from progress in the knowledge of HCC ...
Estelamari Rodriguez and Rogerio C. LilenbaumClinical Lung CancerRodriguez E, Lilenbaum RC. New treatment strategies in patients with advanced non-small-cell lung cancer and per- formance status 2. Clin Lung Cancer. 2008;9:326-330.
In mouse experiments, the researchers found that the antibody slowed the growth of tumors in lung, skin, and breast cancers. Furthermore, it was discovered that the new antibody can prevent a future outbreak of cancer, by leaving behind immune cells that remember how to identify cancer and res...
The main strategy for cancer therapy has focused on targeting malignant cells, leading to markedly improved cure rates for pediatric cancers. However, the recent recognition that the tumor microenvironment contributes to treatment failure or success has led to a paradigm shift [27,28]. The BMM is...
The drug therapy for non-small cell lung cancer (NSCLC) have always been issues of poisonous side effect, acquired drug resistance and narrow applicable population. In this study, we built a novel network analysis method (difference- correlation- enrichm
from patients with acute lymphoblastic leukemia are actually composed of multiple families of genetically distinct leukemia cells [35]. No doubt, that the treatment of such a diverse pathology would not be efficient without understanding of the most general regulatory mechanisms common for all ca...